Tru-D emits UV light that modifies the genetic structure of an infectious cell to effectively kill germs and bacteria. The device calculates the amount of UV energy required to disinfect a room, accounting for variables like size, geometry and equipment layout. Tru-D is used after a staff member disinfects the room via traditional methods.
“The acquisition of this technology is simply another way that we’re working to safeguard the well-being of every single patient who walks through our doors and protect the integrity of our healthcare environment,” said Gar Atchison, CEO of Frye Regional Medical Center.
More articles on infection control and clinical quality:
Glendale Adventist Medical Center’s ban on vaginal-breech deliveries sparks activist protests
Pennsylvania reports its 1st sexually transmitted Zika case
NIH, HHS offer up to $20M in prizes for antibiotic resistance-combating solutions
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.